Tigermed Acquires Marti Farm

Tigermed Acquires Marti Farm

Hangzhou, China-based Tigermed has acquired Zagreb, Croatia-based Marti Farm. Terms of the deal were not disclosed. Marti Farm is a contract research organization (CRO) dedicated to assisting the healthcare, pharmaceutical and food supplement sectors in developing and delivering health-improving outcomes. The company’s global reach is expanding, with results delivered in more than 50 countries to more than 150 clients. Tigermed is a global provider of integrated research and development solutions for the biopharmaceutical and medical device industries. Tigermed represents a worldwide network of more than 100 subsidiaries and 180 service locations with more than 10,000 employees... Read More »
Tigermed Acquires Marti Farm

Huma Acquires German CRO Alcedis

Huma Therapeutics Limited, a global digital health company, announced on January 9 its acquisition of Alcedis GmbH for an undisclosed price. Through the acquisition, Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline, from early stage through to Phase IV hybrid and fully decentralized trials. Alcedis GmbH is a contract research organization (CRO) for data driven clinical research and technology utilization. Headquartered in Hessen, Germany, Alcedis has more than 25 years of clinical trial experience. Huma Therapeutics produces applications that integrate health data from hospital databases as well as patient wearables and... Read More »
Tigermed Acquires Marti Farm

Hillhouse Acquires CRO George Clinical

George Clinical announced on December 9 that it has entered into a sale agreement with Hillhouse, a Beijing-based global investment firm with deep experience in partnering with and supporting healthcare businesses. The George Institute will hold a minority stake in George Clinical following the acquisition and will maintain a collaboration in applicable scientific areas such as in the Global Kidney Patients Trials Network. BofA Securities acted as lead financial advisor on the transaction and Lazard Australia acted as co-advisor. Herbert Smith Freehills LLP acted as legal advisor on the transaction. Financial terms of the transaction were not disclosed. George Clinical is a global clinical... Read More »
Tigermed Acquires Marti Farm

​​Arlington Capital Partners’s Everest Clinical Research Acquires Brightech International

Everest Clinical Research, an Arlington Capital Partners portfolio company, announced on December 1 its acquisition of Brightech International. Brightech will continue to be led by Dr. Tai Xie, the company’s CEO and founder, and the existing management team. Terms of the deal were not disclosed. Founded in 2002, Brightech International is a contract research organization (CRO) that specializes in complex, value-add biostatistics, programming and clinical data management services. Like Everest, Brightech has built a reputation as a critical partner for some of the world’s largest pharmaceutical and biotech companies. In addition to its New Jersey headquarters, Brightech has an expanded... Read More »
Reaction Biology Acquires vivoPharm

Reaction Biology Acquires vivoPharm

Malvern, Pennsylvania-based Reaction Biology has acquired Hummelstown, Pennsylvania-based vivoPharm LLC from Vyant Bio, Inc. Terms of the deal were not disclosed. Founded in 2001, Reaction Biology is a contract research organization that has provided drug discovery and development services to more than 1,800 biopharmaceutical customers worldwide. Reaction has laboratory facilities in Malvern and Hershey, Pennsylvania, and Freiburg, Germany, with approximately 170 employees. vivoPharm is a contract research organization that offers integrated preclinical services in different disease areas to the biotechnology and pharmaceutical industries. According to the LevinPro HC database, this was... Read More »
Reaction Biology Acquires vivoPharm

Symeres Acquires US-Based CRO Exemplify BioPharma

Symeres, a global drug discovery contract research organization (CRO) and contract development and manufacturing organization (CDMO), announced on October 25 the acquisition of Exemplify BioPharma, a US-based CRO that provides integrated end-to-end small molecule chemistry manufacturing and controls services to pharmaceutical and biotech partners. Terms of the deal were not disclosed. Keensight Capital, a private equity firm and the majority shareholder in Symeres, has worked together with the management teams of both companies to facilitate this business combination. This acquisition further strengthens Symeres’ strategic foothold in the United States. Saola Healthcare Partners... Read More »